Affimed N.V. Company Name:
AFMD Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
AFM13 monotherapy: On track to report topline data of the registration-directed REDIRECT trial in the fourth quarter of 2022 AFM13 combination with natural killer (NK) cells: On track to report updated data at a scientific conference in the fourth quarter of 2022 AFM24: Studies co...
HEIDELBERG, Germany, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article covers six blue-chip stocks to sell now. These stocks are severely overvalued or are likely to move down soon due to the coming recession or a slump in demand. The point is analysts’ forecasts are like...